Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2005
12/22/2005WO2005063697A3 Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders
12/22/2005WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives
12/22/2005US20050283007 adamanolol; 1'-(adamantane-1-carbonyl)-[4,4']bipiperidinyl-1-carboxylic acid [2-hydroxy-3-3-(1H-indol-4-yloxy)-propyl]-isopropyl-amide;human epidermal growth factor receptor antagonist; alpha-helix mimetics of Sur-2 (supressor of Ras); anticarcinogenic agent; breast cancer
12/22/2005US20050282908 Substituted aminopropoxyaryl derivatives useful as agonists for LXR
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/22/2005US20050282865 Neurotrophic factor production promoter
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282860 Fexofenadine polymorphs and process for the preparation thereof
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282857 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes
12/22/2005US20050282787 Synthesis of tetracyclines and analogues thereof
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005CA2569843A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
12/22/2005CA2569842A1 New substituted piperidines as modulators of dopamine neurotransmission
12/22/2005CA2569535A1 Dpp-iv inhibitors
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/21/2005EP1607388A1 An improved manufacturing process for methylphenidate and intermediates thereof
12/21/2005EP1607387A2 3,4,4-trisubstituted piperidine derivatives and their use as opioid antagonists
12/21/2005EP1607093A1 Improved delivery of multiple doses of medications
12/21/2005EP1606623A2 Labelling agents for mass spectrometry comprising tertiary amines
12/21/2005EP1606288A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
12/21/2005EP1606282A2 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606259A1 Process for the oxidation of secondary amines into the corresponding nitroxides
12/21/2005EP1606258A1 Cathepsin s inhibitors
12/21/2005EP1606257A1 Synthesis of aryl-substituted piperidines by hydrogenation of aryl-substituted pyridines
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606251A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
12/21/2005EP1606249A2 Compounds, a process for their preparation and their use as dyes and pigments
12/21/2005EP1605941A1 SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1278730B1 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/21/2005EP1255524B1 Dental composition with light stability
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711256A 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
12/21/2005CN1711243A 2-pyridone derivatives as inhibitors of neutrophile elastase
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1709874A Piperidine nitroxide free-radical derivative and its use
12/21/2005CN1709873A Piperidine compound, and its preparing method and use
12/20/2005US6977303 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
12/20/2005US6977265 Piperidine CCR-3 receptor antagonists
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977260 Piperidinyl prostaglandin E analogs
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/20/2005CA2275593C Micro-particulate form of a tetrahydropyridin derivative
12/20/2005CA2233560C Sulfonamide inhibitors of matrix metalloproteinases
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/15/2005WO2005118651A1 Alkoxyamines containing a radically polymerizable group
12/15/2005WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/15/2005WO2005118537A2 Arylpiperazine derivatives as adrenergic receptor antagonists
12/15/2005WO2005117882A2 Hydroxamic acid derivatives as metalloprotease inhibitors
12/15/2005WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands
12/15/2005WO2005117543A2 N-sulfonylcarboximidamide apoptosis promoters
12/15/2005WO2005097768A3 Novel gamma secretase inhibitors
12/15/2005WO2005075455A3 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
12/15/2005US20050277775 Process for the preparation of keto compounds
12/15/2005US20050277772 Monophosphine compound, transition metal complex thereof and production method of optically active compound using the complex as asymmetric catalyst
12/15/2005US20050277667 Manufacturing process for methyl phenidate and intermediates thereof
12/15/2005US20050277666 Process of preparing N-ureidoalkyl-piperidines
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005CA2567831A1 N-sulfonylcarboximidamide apoptosis promoters
12/15/2005CA2561858A1 Arylsulfonamides and uses related thereto
12/15/2005CA2510001A1 A process for the preparation of keto compounds
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604981A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/14/2005EP1604980A1 DPP-IV inhibitors
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1274430B1 Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome
12/14/2005EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005CN1708489A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1231470C N-alkoxy-4, 4-dioxy-polyalkyl-piperidines as polymerisation in hibitors
12/14/2005CN1231469C Optically active amlodipine resolving process
12/14/2005CN1231468C Chemical compounds
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231466C New piperidine derivatives
12/13/2005US6974872 Process for production of piperidine derivatives
12/13/2005US6974827 For use as pesticides and herbicides
12/13/2005US6974825 piperidines or pyrroles with an amido- or sulfonamidophenylamino group; reductive amination of a piperidone with a substituted arylamine then further arylation; ligand for the delta opiod receptor; less side effects than current mu agonists; oral
12/13/2005US6974824 N-substituted-4-(m-hydroxyphenyl)piperidine derivated and esters thereof, used to bind a kappa opioid receptor; treating drug addiction
12/13/2005CA2280151C Arylsulfonyl hydroxamic acid derivatives
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/08/2005WO2005116029A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115972A1 Therapeutic compounds
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005090294A3 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
12/08/2005WO2005089353A3 (s)-amlodipine malate
12/08/2005WO2004112729A8 Dual function compounds and uses thereof
1 ... 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 ... 380